Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03882450 · ClinicalTrials.gov registry record · NA
Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT03882450: Completed NA study, sponsored by Emory University.
NCT03882450 is a NA study that has completed, run by Emory University. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03882450, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
The purpose of this study is to determine how often heart or chest surgery in children leads to problems with the movement of the vocal folds.
Primary Outcome
The number of days of postoperative stay in the hospital will be compiled by reviewing the medical records of all children 18 and under who underwent CCS (as defined by ICD-9-CM congenital heart disease procedure codes) from January 1, 2011 to December 31, 2016.
Interventions
- PROCEDURE Flexible fiberoptic laryngoscopy
- PROCEDURE Laryngeal ultrasonography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2020-03-13 |
| Phase | NA |
What the finished NCT03882450 record still lists
NCT03882450 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Flexible fiberoptic laryngoscopy is the first listed.
NCT03882450 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03882450 about?
NCT03882450 is a clinical study titled "Universal Screening for Vocal Fold Motion Impairment in Children Undergoing Congenital Cardiac Surgery". The purpose of this study is to determine how often heart or chest surgery in children leads to problems with the movement of the vocal folds.
What is the current status of trial NCT03882450?
This trial is currently completed. It is a NA study. The enrollment target is 94 participants. The study started on 2019-01-01. Estimated completion is 2020-03-13.
What interventions are being tested in trial NCT03882450?
The interventions under investigation include: Flexible fiberoptic laryngoscopy (PROCEDURE), Laryngeal ultrasonography (PROCEDURE).
Who is sponsoring clinical trial NCT03882450?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03882450's enrollment target sits among peer trials
94 935th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI